Pinnacle Wealth Planning Services’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.4K Buy
1,618
+64
+4% +$1.7K ﹤0.01% 1364
2026
Q1
$41.7K Buy
1,554
+59
+4% +$1.77K ﹤0.01% 1300
2025
Q4
$46K Buy
+1,495
New +$46.6K ﹤0.01% 1250
2021
Q1
Sell
-1,681
Closed -$68K 991
2020
Q4
$68K Buy
+1,681
New +$62.8K 0.02% 643

Other funds holding GMAB

Pinnacle Wealth Planning Services's GMAB Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Genmab (GMAB) stake by 4.1% in Q2 2026, buying an estimated $1.7K and bringing the position to 1,618 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

Pinnacle Wealth Planning Services first reported a position in GMAB in Q4 2020 and has held it in 4 quarters since. The position peaked at $68K in Q4 2020. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Pinnacle Wealth Planning Services held 1,618 shares of Genmab worth $44.4K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 64 Genmab shares in Q2 2026, an estimated $1.7K.
  • Genmab made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1364 holding.
  • Pinnacle Wealth Planning Services first reported a position in Genmab in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's Genmab position peaked at $68K in Q4 2020.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.